Product Images Rapamune

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 23 images provide visual information about the product associated with Rapamune NDC 0008-1040 by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - rapamune 01

Chemical Structure - rapamune 01

Figure 1 - rapamune 02

Figure 1 - rapamune 02

The text appears to be a table showing the results of a clinical trial for a treatment involving a drug called Siolimus. The trial appears to have had two phases, a treatment phase and an observation phase. The table shows the number of subjects and their response to the drug after 12 months. The response is measured in some units which cannot be determined from the given text.*

Logo - rapamune 03

Logo - rapamune 03

This text is a label or disclaimer for a pharmaceutical product, indicating that it is distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc, a company based in Philadelphia.*

Logo - rapamune 04

Logo - rapamune 04

This is a description for a medication that is distributed by Wyeth Pharmaceuticals LLC, which is a subsidiary of Pfizer Inc. The location of PizerInc is Philadelphia, PA 19101.*

Figure - rapamune 05

Figure - rapamune 05

Figure 1 - rapamune 06

Figure 1 - rapamune 06

Figure 2 - rapamune 07

Figure 2 - rapamune 07

Figure 3 - rapamune 08

Figure 3 - rapamune 08

Figure 4 - rapamune 09

Figure 4 - rapamune 09

Figure 5 - rapamune 10

Figure 5 - rapamune 10

Figure 6 - rapamune 11

Figure 6 - rapamune 11

Figure 7 - rapamune 12

Figure 7 - rapamune 12

Logo - rapamune 13

Logo - rapamune 13

This text is a statement indicating that the product is distributed by Wyeth Pharmaceuticals LLC, which is a subsidiary of Pfizer Inc, located in Philadelphia with a zip code of 19101.*

PRINCIPAL DISPLAY PANEL - 60 mL Bottle Label - rapamune 14

PRINCIPAL DISPLAY PANEL - 60 mL Bottle Label - rapamune 14

This is a description of a medication - Rapamune oral solution. Each milliliter of the solution contains 1 mg of the active ingredient, sirolimus. The solution also contains a mixture of propylene glycol, phosphatidylcholine derived from soylecithin, and polysorbate 80. It is intended for oral use only. The NDC number is 0008-1030-04 and the bottle contains 60 mL of the solution.*

PRINCIPAL DISPLAY PANEL - 60 mL Bottle Carton - rapamune 15

PRINCIPAL DISPLAY PANEL - 60 mL Bottle Carton - rapamune 15

Rapamune is an oral solution used for medication. Each ml contains 1 mg of sirolimus and other components. This solution should be used only orally and within a month of opening. It also contains a mixture of propylene glycol and phosphatidylcholine derived from soy lecithin. The dosage and usage information are available in accompanying instructions. This solution is distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. Protect it from light.*

PRINCIPAL DISPLAY PANEL - 60 mL Kit Carton - rapamune 16

PRINCIPAL DISPLAY PANEL - 60 mL Kit Carton - rapamune 16

PRINCIPAL DISPLAY PANEL - 0.5 mg Tablet Bottle Label - rapamune 17

PRINCIPAL DISPLAY PANEL - 0.5 mg Tablet Bottle Label - rapamune 17

This is a medication guide for a drug called "Sirolimus". It is made in Japan and distributed by Pfizer Inc. The guide provides instructions for dispensing and storing the medication, as well as notes on the type of containers to be used. It also specifies that the drug is for oral use only and that it comes in a pack of 100 tablets, which can only be prescribed by a healthcare provider.*

Package Label – Principal Display Panel – CSAT Foil Package 0.5 mg - rapamune 18

Package Label – Principal Display Panel – CSAT Foil Package 0.5 mg - rapamune 18

PRINCIPAL DISPLAY PANEL - 0.5 mg Tablet Blister Card Carton - rapamune 19

PRINCIPAL DISPLAY PANEL - 0.5 mg Tablet Blister Card Carton - rapamune 19

Rapamune (sirolimus) Tablets is a prescription drug that comes in a unit-dose package of 100 tablets, with ten blister cards of ten tablets each. This medication guide should always be dispensed with the tablets. It is for oral use, and the dosage and use instructions should be followed as per the prescribing information. These tablets can be stored at room temperature, preferably protected from light. This unit-dose package is not child-resistant and should be kept out of reach of children. The drug is distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., and made in Japan.*

PRINCIPAL DISPLAY PANEL - 1 mg Tablet Bottle Label - rapamune 20

PRINCIPAL DISPLAY PANEL - 1 mg Tablet Bottle Label - rapamune 20

This is the dosage and usage information for a medicine named Rapamune (sirolimus) tablets. It is advised to store the tablets in a room temperature ranging between 2°C to 25°C. The medicine should be dispensed in tight, light-resistant, and child-resistant containers. The medicine is distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc based in Philadelphia. Always dispense the medication with a medication guide. The NDC code for the medicine is 0008-1041-05 and the lot number is PAA114678. The rest of the text includes non-English characters and is not available for interpretation.*

Principal Display Panel - 1 mg Tablets - Redipak - rapamune 21

Principal Display Panel - 1 mg Tablets - Redipak - rapamune 21

PRINCIPAL DISPLAY PANEL - 1 mg Tablet Blister Card Carton - rapamune 22

PRINCIPAL DISPLAY PANEL - 1 mg Tablet Blister Card Carton - rapamune 22

Rapamune tablets are used for oral purposes only. The pack consists of 100 tablets in unit doses, with 10 blister cards, each comprising of ten tablets. It is essential to refer to the prescribing information for dosage and usage. The package is not child-resistant and must be kept out of the reach of children. The medication should be protected from light and must be stored in a controlled room temperature of 20° to 25°C. Finally, these tablets are manufactured in Japan and are distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., Philadelphia, PA.*

PRINCIPAL DISPLAY PANEL - 2 mg Tablet Bottle Label - rapamune 23

PRINCIPAL DISPLAY PANEL - 2 mg Tablet Bottle Label - rapamune 23

This is a medication description with dosage instructions and storage information. It also provides information on the distributor and manufacturing location. The medication is called Rapamune and contains sirolimus. It should only be taken orally, and come in 100 tablet packs. It should be stored in a tight, light-resistant, and child-resistant container at room temperature. A medication guide should always be dispensed with the tablets. The lot and expiration date are indicated, but the dosage information is not provided and should be obtained from an accompanying prescribing information. There is also a National Drug Code (NDC) and a Global Trade Item Number (GTIN) provided for tracking purposes.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.